On December 7, the Annual Meeting of Clinical Embryology Progress & Beijing Society of Obstetrics and Gynecology Embryology Committee concluded successfully in Shijiazhuang, Hebei. The symposium brought together leading experts and scholars from across the country to discuss the latest advancements, clinical insights, and future directions in clinical embryology.
A major highlight of the conference was the Oocyte and Embryo Vitrification and Warming Skills Training. This session featured a practical "theory-meets-practice" framework, offering a high-value, hands-on classroom environment for embryologists to refine their clinical skills.
As a dedicated long-term partner in the ART field, VitaVitro provided comprehensive material and technical support for this practical training. Notably, VitaVitro's proprietary vitrification kit became the flagship choice of the hands-on session, earning widespread recognition from participants for its consistent performance and clinical reliability.
Technical Spotlight: VitaVitro Cryopreservation System
1. Global Regulatory Approvals
VitaVitro's vitrification and warming kits are currently the only products in China to hold concurrent US FDA clearance, EU CE MDR Class III certification, and China NMPA approval, representing the highest level of global regulatory recognition for safety and efficacy.
2. Cellular Protection
The standard base medium effectively cushions operational and osmotic stress, ensuring maximum protection for cellular integrity throughout the workflow.
3. Dual-Assurance Protocol
The optimized protocol provides double the rinsing volume to ensure complete removal of residual media, maintaining the highest quality standards for cryopreservation.
4. Flexible Packaging Options
Available in multiple specifications and kit sizes to seamlessly adapt to different laboratory workflows and daily throughput demands.
Looking Ahead
While the symposium has concluded, our commitment to advancing reproductive medicine remains unchanged. VitaVitro looks forward to collaborating further with industry peers, focused on driving clinical technologies forward and supporting better patient outcomes in reproductive health.